193 related articles for article (PubMed ID: 23812204)
1. Effectiveness of oral iron chelator treatment with deferasirox in an aceruloplasminemia patient with a novel ceruloplasmin gene mutation.
Suzuki Y; Yoshida K; Aburakawa Y; Kuroda K; Kimura T; Terada T; Kono S; Miyajima H; Yahara O
Intern Med; 2013; 52(13):1527-30. PubMed ID: 23812204
[TBL] [Abstract][Full Text] [Related]
2. Hepatic but not brain iron is rapidly chelated by deferasirox in aceruloplasminemia due to a novel gene mutation.
Finkenstedt A; Wolf E; Höfner E; Gasser BI; Bösch S; Bakry R; Creus M; Kremser C; Schocke M; Theurl M; Moser P; Schranz M; Bonn G; Poewe W; Vogel W; Janecke AR; Zoller H
J Hepatol; 2010 Dec; 53(6):1101-7. PubMed ID: 20801540
[TBL] [Abstract][Full Text] [Related]
3. Aceruloplasminaemia: a family with a novel mutation and long-term therapy with deferasirox.
Lindner U; Schuppan D; Schleithoff L; Habeck JO; Grodde T; Kirchhof K; Stoelzel U
Horm Metab Res; 2015 Apr; 47(4):303-8. PubMed ID: 25089372
[TBL] [Abstract][Full Text] [Related]
4. Deferasirox Might Be Effective for Microcytic Anemia and Neurological Symptoms Associated with Aceruloplasminemia: A Case Report and Review of the Literature.
Miyake Z; Nakamagoe K; Yoshida K; Kondo T; Tamaoka A
Intern Med; 2020 Jul; 59(14):1755-1761. PubMed ID: 32238721
[TBL] [Abstract][Full Text] [Related]
5. Aceruloplasminaemia: a disorder of diabetes and neurodegeneration.
Calder GL; Lee MH; Sachithanandan N; Bell S; Zeimer H; MacIsaac RJ
Intern Med J; 2017 Jan; 47(1):115-118. PubMed ID: 28076908
[TBL] [Abstract][Full Text] [Related]
6. Does aceruloplasminemia modulate iron phenotype in thalassemia intermedia?
Pelucchi S; Pelloni I; Arosio C; Mariani R; Piperno A
Blood Cells Mol Dis; 2016 Mar; 57():112-4. PubMed ID: 26777753
[No Abstract] [Full Text] [Related]
7. Novel ceruloplasmin mutation causing aceruloplasminemia with hepatic iron overload and diabetes without neurological symptoms.
Rusticeanu M; Zimmer V; Schleithoff L; Wonney K; Viera J; Zimmer A; Hübschen U; Bohle RM; Grünhage F; Lammert F
Clin Genet; 2014 Mar; 85(3):300-1. PubMed ID: 23557349
[No Abstract] [Full Text] [Related]
8. Neurodegeneration With Brain Iron Accumulation: A Novel Mutation in the Ceruloplasmin Gene.
Stelten BML; van Ommen W; Keizer K
JAMA Neurol; 2019 Feb; 76(2):229-230. PubMed ID: 30383083
[No Abstract] [Full Text] [Related]
9. Aceruloplasminemia in a Turkish adolescent with a novel mutation of ceruloplasmin gene: the first diagnosed case from Turkey.
Meral Gunes A; Sezgin Evim M; Baytan B; Iwata A; Hida A; Avci R
J Pediatr Hematol Oncol; 2014 Oct; 36(7):e423-5. PubMed ID: 25247888
[TBL] [Abstract][Full Text] [Related]
10. Aceruloplasminemia With Positive Ceruloplasm Gene Mutation.
Kang HG; Kim M; Lee SC
JAMA Ophthalmol; 2016 Jul; 134(7):e160816. PubMed ID: 27416276
[No Abstract] [Full Text] [Related]
11. Genetic and Clinical Heterogeneity in Thirteen New Cases with Aceruloplasminemia. Atypical Anemia as a Clue for an Early Diagnosis.
Vila Cuenca M; Marchi G; Barqué A; Esteban-Jurado C; Marchetto A; Giorgetti A; Chelban V; Houlden H; Wood NW; Piubelli C; Dorigatti Borges M; Martins de Albuquerque D; Yotsumoto Fertrin K; Jové-Buxeda E; Sanchez-Delgado J; Baena-Díez N; Burnyte B; Utkus A; Busti F; Kaubrys G; Suku E; Kowalczyk K; Karaszewski B; Porter JB; Pollard S; Eleftheriou P; Bignell P; Girelli D; Sanchez M
Int J Mol Sci; 2020 Mar; 21(7):. PubMed ID: 32235485
[TBL] [Abstract][Full Text] [Related]
12. Criteria for early identification of aceruloplasminemia.
Ogimoto M; Anzai K; Takenoshita H; Kogawa K; Akehi Y; Yoshida R; Nakano M; Yoshida K; Ono J
Intern Med; 2011; 50(13):1415-8. PubMed ID: 21720062
[TBL] [Abstract][Full Text] [Related]
13. New mutation of the ceruloplasmin gene in the case of a neurologically asymptomatic patient with microcytic anaemia, obesity and supposed Wilson's disease.
Ondrejkovičová M; Dražilová S; Drakulová M; Siles JL; Zemjarová Mezenská R; Jungová P; Fabián M; Rychlý B; Žigrai M
BMC Gastroenterol; 2020 Apr; 20(1):95. PubMed ID: 32264837
[TBL] [Abstract][Full Text] [Related]
14. Aceruloplasminemia: an update.
Kono S
Int Rev Neurobiol; 2013; 110():125-51. PubMed ID: 24209437
[TBL] [Abstract][Full Text] [Related]
15. Treatment of symptomatic heterozygous aceruloplasminemia with oral zinc sulphate.
Kuhn J; Bewermeyer H; Miyajima H; Takahashi Y; Kuhn KF; Hoogenraad TU
Brain Dev; 2007 Aug; 29(7):450-3. PubMed ID: 17307325
[TBL] [Abstract][Full Text] [Related]
16. Aceruloplasminemia and putaminal cavitation.
Riboldi GM; Anstett K; Jain R; Lau H; Swope D
Parkinsonism Relat Disord; 2018 Jun; 51():121-123. PubMed ID: 29534945
[No Abstract] [Full Text] [Related]
17. Superficial siderosis associated with aceruloplasminemia. Case report.
Matsushima A; Yoshida T; Yoshida K; Ohara S; Toyoshima Y; Kakita A; Ikeda S
J Neurol Sci; 2014 Apr; 339(1-2):231-4. PubMed ID: 24607334
[TBL] [Abstract][Full Text] [Related]
18. Clinical relevance of heterozygosis for aceruloplasminemia.
Borges MD; de Albuquerque DM; Lanaro C; Costa FF; Fertrin KY
Am J Med Genet B Neuropsychiatr Genet; 2019 Jun; 180(4):266-271. PubMed ID: 30901137
[TBL] [Abstract][Full Text] [Related]
19. Diagnosing aceruloplasminemia: navigating through red herrings.
Kharel Z; Kharel H; Phatak PD
Ann Hematol; 2024 Jun; 103(6):2173-2176. PubMed ID: 38637332
[TBL] [Abstract][Full Text] [Related]
20. Aceruloplasminaemia: a rare but important cause of iron overload.
Doyle A; Rusli F; Bhathal P
BMJ Case Rep; 2015 May; 2015():. PubMed ID: 25976187
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
